Weaver Consulting Group’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Sell |
1,162
-114
| -9% | -$21.2K | 0.06% | 229 |
|
|
2025
Q1 | $267K | Sell |
1,276
-73
| -5% | -$15.3K | 0.08% | 184 |
|
|
2024
Q4 | $240K | Buy |
1,349
+74
| +6% | +$13.2K | 0.07% | 187 |
|
|
2024
Q3 | $252K | Hold |
1,275
| – | – | 0.08% | 187 |
|
|
2024
Q2 | $219K | Buy |
+1,275
| New | +$219K | 0.08% | 186 |
|
|
2023
Q1 | – | Sell |
-1,244
| Closed | -$201K | – | 180 |
|
|
2022
Q4 | $201K | Buy |
+1,244
| New | +$201K | 0.1% | 168 |
|
|
2022
Q2 | – | Sell |
-1,396
| Closed | -$226K | – | 167 |
|
|
2022
Q1 | $226K | Sell |
1,396
-108
| -7% | -$17.5K | 0.11% | 153 |
|
|
2021
Q4 | $204K | Buy |
+1,504
| New | +$204K | 0.1% | 162 |
|
|
2020
Q4 | – | Sell |
-562
| Closed | -$49K | – | 140 |
|
|
2020
Q3 | $49K | Hold |
562
| – | – | 0.03% | 269 |
|
|
2020
Q2 | $55K | Buy |
562
+220
| +64% | +$21.5K | 0.03% | 244 |
|
|
2020
Q1 | $26K | Sell |
342
-55
| -14% | -$4.18K | 0.02% | 293 |
|
|
2019
Q4 | $30K | Buy |
397
+74
| +23% | +$5.59K | 0.02% | 305 |
|
|
2019
Q3 | $22K | Hold |
323
| – | – | 0.01% | 331 |
|
|
2019
Q2 | $23K | Hold |
323
| – | – | 0.01% | 321 |
|
|
2019
Q1 | $25K | Buy |
+323
| New | +$25K | 0.01% | 666 |
|